An Open Label Phase II Study of Romiplostim for Chemotherapy Induced Thrombocytopenia
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Romiplostim (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 06 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2018.
- 07 Jun 2016 Interim results (n = 21) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 05 May 2016 Planned number of patients changed from 60 to 64.